Hasil Pencarian - Liteng Lin
- Menampilkan 1 - 14 hasil dari 14
-
1
High Expression of Ten Eleven Translocation 1 Is Associated with Poor Prognosis in Hepatocellular Carcinoma oleh Haopeng Wen, Tengfei Ji, Liteng Lin, Nan Cheng, Kangshun Zhu, Liangqi Cao
Diterbitkan 2023-01-01
Artikel -
2
Risk Factors, Patterns, and Long-Term Survival of Recurrence After Radiofrequency Ablation With or Without Transarterial Chemoembolization for Hepatocellular Carcinoma oleh Jingjun Huang, Wensou Huang, Yongjian Guo, Mingyue Cai, Jingwen Zhou, Liteng Lin, Kangshun Zhu
Diterbitkan 2021-05-01
Artikel -
3
LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2 oleh Yongjian Guo, Mingjun Bai, Liteng Lin, Jingjun Huang, Yongcheng An, Licong Liang, Yaohong Liu, Wensou Huang
Diterbitkan 2019-10-01
Artikel -
4
-
5
-
6
Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation oleh Zecong Xiao, Tan Li, Xinyao Zheng, Liteng Lin, Xiaobin Wang, Bo Li, Jingjun Huang, Yong Wang, Xintao Shuai, Kangshun Zhu
Diterbitkan 2023-03-01
Artikel -
7
Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study oleh Mingyue Cai, Mingyue Cai, Wensou Huang, Wensou Huang, Jingjun Huang, Jingjun Huang, Wenbo Shi, Wenbo Shi, Yongjian Guo, Yongjian Guo, Licong Liang, Licong Liang, Jingwen Zhou, Jingwen Zhou, Liteng Lin, Liteng Lin, Bihui Cao, Bihui Cao, Ye Chen, Ye Chen, Juan Zhou, Kangshun Zhu, Kangshun Zhu
Diterbitkan 2022-03-01
Artikel -
8
Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled s... oleh Jingjun Huang, Mingyue Cai, Wensou Huang, Yongjian Guo, Jingwen Zhou, Licong Liang, Liteng Lin, Zhimei Zhou, Hui Lian, Mingji He, Kangshun Zhu, Yuanyuan Ji
Diterbitkan 2022-01-01
Artikel -
9
Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched study oleh Yongjian Guo, Jingqiang Wu, Licong Liang, Kangshun Zhu, Jingwen Zhou, Liteng Lin, Ye Chen, Bihui Cao, Mingji He, Hui Lian, Wensou Huang, Mingyue Cai
Diterbitkan 2023-09-01
Artikel -
10
Regorafenib enhances anti-tumor efficacy of immune checkpoint inhibitor by regulating IFN-γ/NSDHL/SREBP1/TGF-β1 axis in hepatocellular carcinoma oleh Lulu Xie, Mingyu Liu, Mingyue Cai, Wensou Huang, Yongjian Guo, Licong Liang, Weiguo Cai, Jianxin Liu, Wei Liang, Yitong Tan, Miaoling Lai, Liteng Lin, Kangshun Zhu
Diterbitkan 2023-03-01
Artikel -
11
T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma oleh Yong Wang, Jianxin Liu, Xiaobin Wang, Qiaoyun Zhang, Jingwen Zhou, Zecong Xiao, Shaohui Deng, Xiaoyang Hong, Wensou Huang, Mingyue Cai, Yongjian Guo, Jingjun Huang, Liteng Lin, Kangshun Zhu
Diterbitkan 2023-02-01
Artikel -
12
Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases oleh Mingyu Liu, Lulu Xie, Yuying Zhang, Jianning Chen, Xiang Zhang, Ye Chen, Wensou Huang, Mingyue Cai, Licong Liang, Miaoling Lai, Jingjun Huang, Yongjian Guo, Liteng Lin, Kangshun Zhu
Diterbitkan 2023-01-01
Artikel -
13
Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation oleh Liteng Lin, Hengye Gong, Rui Li, Jingjun Huang, Mingyue Cai, Tian Lan, Wensou Huang, Yongjian Guo, Zhimei Zhou, Yongcheng An, Zhiwei Chen, Licong Liang, Yong Wang, Xintao Shuai, Kangshun Zhu
Diterbitkan 2020-04-01
Artikel -
14
Microbial-derived Urolithin A Targets GLS1 to Inhibit Glutaminolysis and Attenuate Cirrhotic Portal HypertensionSummary oleh Rui Li, Zhile Liu, Wensou Huang, Yongjian Guo, Chan Xie, Hongmei Wu, Jianxin Liu, Xiaoyang Hong, Xiaobin Wang, Jingjun Huang, Mingyue Cai, Zhaoxiong Guo, Licong Liang, Liteng Lin, Kangshun Zhu
Diterbitkan 2024-01-01
Artikel